Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe revision label on the study page was updated from v3.6.5 to v3.6.6, indicating a small metadata update to the record. This change does not modify the study content or data.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.6.5 has been added, replacing the previous v3.6.4. This indicates the study documents have been updated to the new revision.SummaryDifference0.0%

- Check39 days agoChange Detected- The page revision was updated from v3.6.3 to v3.6.4, indicating a small metadata update to the study record. This does not change the study details, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check46 days agoChange DetectedNo additions or deletions were identified for this page, indicating the content remained the same between versions.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a small update to the page rather than changes to study details. This change reflects a backend or content polish and does not affect the recorded trial information presented on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, signaling a newer version of the page. This appears to be a small update to the page's text or formatting rather than a change to study data.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.